Skip to main content

and
  1. No Access

    Article

    Cross resistance and cellular uptake of 4′-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin

    A new analog of doxorubicin, 4′-O-methyldoxorubicin, was previously reported to have a pronounced activity agianst L1210 leukemia, which shows a natural partial resistance to doxorubicin itself. In the present...

    A. Di Marco, T. Skovsgaard, A. M. Casazza in Cancer Chemotherapy and Pharmacology (1981)

  2. No Access

    Article

    In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor

    The antitumor effect of daunorubicin and of two preparations of daunorubicin-DNA complexes were compared in equitoxic doses against the Ehrlich ascites tumor and in a subline of this tumor resistant to daunoru...

    T. Skovsgaard in Cancer Chemotherapy and Pharmacology (1979)